← Open Payments lookup

DANIEL CONTRERAS: Open Payments

NPI 1174134951 · CHINO HILLS, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$2,779 in 111 payments from 13 companies in 2025. Trend: 2023 $69 · 2024 $680 · 2025 $2,779

Food & beverage: $2,695Education: $84
CompanyPaymentsAmount
Vanda Pharmaceuticals Inc.17$623
Otsuka America Pharmaceutical, Inc.21$368
E.R. Squibb & Sons, L.L.C.15$314
Alkermes, Inc.9$307
Janssen Pharmaceuticals, Inc11$264
ABBVIE INC.16$260
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)6$254
Teva Pharmaceuticals USA, Inc.8$210
Neurocrine BioSciences, Inc.3$69
Lundbeck LLC2$49

Products named: HETLIOZ, COBENFY, REXULTI, VRAYLAR, CAPLYTA, INVEGA SUSTENNA, ARISTADA, ABILIFY ASIMTUFII.

Industry payments across CA — which companies pay providers there.